US$ 25.50
new glp-1 agonist Machine learning designs GCGR/GLP-1R dual agonists with enhanced biological potency This is a blog that
Description
GLP-1 receptor agonists are medications used to manage obesity and type 2 diabetes
The development of dual GIPRGLP1R coagonists that bind to either one or the other receptor (sequence-mixed dual agonists) has emerged as an innovative therapeutic strategy for obesity and type 2 diabetes

Visit Us!

Includes PREDIMED data and EU health claim context.

GLP-1RA only reduced the risk of nonfatal stroke
